These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 15452761

  • 1. Direct medical costs of age-related macular degeneration in Italian hospital ophthalmology departments. A multicenter, prospective 1-year study.
    Garattini L, Castelnuovo E, Lanzetta P, Viscarra C, Ricci E, Parazzini F, CARMA Study Group.
    Eur J Health Econ; 2004 Feb; 5(1):22-7. PubMed ID: 15452761
    [Abstract] [Full Text] [Related]

  • 2. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
    Cruess AF, Zlateva G, Xu X, Soubrane G, Pauleikhoff D, Lotery A, Mones J, Buggage R, Schaefer C, Knight T, Goss TF.
    Pharmacoeconomics; 2008 Feb; 26(1):57-73. PubMed ID: 18088159
    [Abstract] [Full Text] [Related]

  • 3. [The treatment of the exsudative age-related macular degeneration with choroidal neovascular membrane, its possibilities and economical indexes].
    Karel I.
    Cesk Slov Oftalmol; 2007 Sep; 63(5):311-9. PubMed ID: 17915581
    [Abstract] [Full Text] [Related]

  • 4. Drusen Volume and Retinal Pigment Epithelium Abnormal Thinning Volume Predict 2-Year Progression of Age-Related Macular Degeneration.
    Folgar FA, Yuan EL, Sevilla MB, Chiu SJ, Farsiu S, Chew EY, Toth CA, Age Related Eye Disease Study 2 Ancillary Spectral-Domain Optical Coherence Tomography Study Group.
    Ophthalmology; 2016 Jan; 123(1):39-50.e1. PubMed ID: 26578448
    [Abstract] [Full Text] [Related]

  • 5. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.
    Coleman AL, Yu F.
    Ophthalmology; 2008 Jan; 115(1):18-25. PubMed ID: 17572499
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Burden of illness of neovascular age-related macular degeneration in Canada.
    Cruess A, Zlateva G, Xu X, Rochon S.
    Can J Ophthalmol; 2007 Dec; 42(6):836-43. PubMed ID: 18026200
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Cost-utility analysis of ranibizumab (Lucentis) in neovascular macular degeneration].
    Neubauer AS, Holz FG, Schrader W, Back EI, Kühn T, Hirneiss C, Kampik A.
    Klin Monbl Augenheilkd; 2007 Sep; 224(9):727-32. PubMed ID: 17846963
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.
    Olk RJ, Friberg TR, Stickney KL, Akduman L, Wong KL, Chen MC, Levy MH, Garcia CA, Morse LS.
    Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevalence of reticular pseudodrusen in age-related macular degeneration with newly diagnosed choroidal neovascularisation.
    Cohen SY, Dubois L, Tadayoni R, Delahaye-Mazza C, Debibie C, Quentel G.
    Br J Ophthalmol; 2007 Mar; 91(3):354-9. PubMed ID: 16973663
    [Abstract] [Full Text] [Related]

  • 17. [Age-related Macular Degeneration in the Japanese].
    Yoshimura N.
    Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756
    [Abstract] [Full Text] [Related]

  • 18. [Cost-effectiveness of photodynamic therapy in age-related macular degeneration].
    Muslera E, Natal C.
    Arch Soc Esp Oftalmol; 2006 Apr; 81(4):199-204. PubMed ID: 16688643
    [Abstract] [Full Text] [Related]

  • 19. Chronic venous insufficiency: the effects of health-care reforms on the cost of treatment and hospitalisation--an Italian perspective.
    Allegra C.
    Curr Med Res Opin; 2003 Apr; 19(8):761-9. PubMed ID: 14687448
    [Abstract] [Full Text] [Related]

  • 20. Drusen volume development over time and its relevance to the course of age-related macular degeneration.
    Schlanitz FG, Baumann B, Kundi M, Sacu S, Baratsits M, Scheschy U, Shahlaee A, Mittermüller TJ, Montuoro A, Roberts P, Pircher M, Hitzenberger CK, Schmidt-Erfurth U.
    Br J Ophthalmol; 2017 Feb; 101(2):198-203. PubMed ID: 27044341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.